Recent Patents on Anti-Cancer Drug Discovery

Khurshid Zaman  
Bentham Science Publishers
USA

Back

c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer

Volume:1   Issue:3
Pp: 305-326
Sam Robson, Stella Pelengaris and Michael Khan
DOI: 10.2174/157489206778776934

Order Reprints Order Eprints

Mitocans: Mitochondrial Targeted Anti-Cancer Drugs as Improved Therapies and Related Patent Documents

Volume:1   Issue:3
Pp: 327-346
Stephen J. Ralph, Pauline Low, Langfeng Dong, Alfons Lawen and Jiri Neuzil
DOI: 10.2174/157489206778776952

Order Reprints Order Eprints

Last Generation of Amino-Bisphosphonates (N-BPs) and Cancer Angiogenesis: A New Role for These Drugs?

Volume:1   Issue:3
Pp: 383-396
Daniele Santini, Gaia Schiavon, Silvia Angeletti, Bruno Vincenzi, Simona Gasparro, Claudia Grilli, Annalisa La Cesa, Vladimir Virzi, Valentina Leoni, Alfredo Budillon, Santolo R. Addeo, Michele Caraglia, Giordano Dicuonzo and Giuseppe Tonini
DOI: 10.2174/157489206778776989

Order Reprints Order Eprints

Bortezomib in the Treatment of Cancer

Volume:1   Issue:3
Pp: 397-403
Aldo M. Roccaro, Angelo Vacca and Domenico Ribatti
DOI: 10.2174/157489206778776925

Order Reprints Order Eprints

Patent Annotations

Volume:1   Issue:3
Pp: 405-408
Bentham Science Publishers
DOI: 10.2174/157489206778776970

Order Reprints Order Eprints

Patent Selections promotion: free to download

Volume:1   Issue:3
Pp: 409-411
Bentham Science Publishers
DOI: 10.2174/157489206778776943

Order Reprints Order Eprints